Advertisement

Topics

CRISPR and Massachusetts General Hospital partner to develop T-cell therapies

19:00 EDT 23 Aug 2017 | Pharmaceutical Technology

CRISPR Therapeutics has entered a new research collaboration and licence option agreement with Massachusetts General Hospital Cancer Centre (MGHCC) to develop new T-cell therapies for cancer.

Original Article: CRISPR and Massachusetts General Hospital partner to develop T-cell therapies

NEXT ARTICLE

More From BioPortfolio on "CRISPR and Massachusetts General Hospital partner to develop T-cell therapies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...